Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Gynecologic Oncology Physician in Birmingham, AL
NPI: 1255313193Primary Employer
University of Alabama Health Services Foundation, PC.
uabmedicine.org
HQ Phone
Get Charles's Phone Numberphone_androidMobile
Get Charles's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardAL State Medical License
SD State Medical License
2027
MS State Medical License
2017 - 2026
AL State Medical License
1999 - 2025
TX State Medical License
2006 - 2024
American Board of Obstetrics and Gynecology
Obstetrics & Gynecology
American Board of Obstetrics and Gynecology
Gynecologic Oncology
University of Alabama at Birmingham School of Public Health
Masters • Clinical and Translational Sciences
2012 - 2014
Medical University of South Carolina (MUSC)
medicine.musc.edu
Medical School
Until 1998
Citadel
BS • Biological Sciences
1990 - 1994
University of Alabama Medical Center
Residency • Obstetrics and Gynecology
1998 - 2002
Fellowship • Gynecologic Oncology
2002 - 2005
University of South Carolina
No Degree • 1992 - 1993
1992 - 1993
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 61 | 134 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 58 | 68 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 43 | 47 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 14 | 14 |
Authors: Britt Erickson, Laura Daily, Warner Huh, John Straughn
Journal: J Low Genit Tract Dis
Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer.
Authors: Laura Havrilesky, Rex Bentley, Warner Huh
Journal: Gynecol Oncol
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, RADIATION: External Beam Radiation Therapy, DRUG: Cisplatin, RADIATION: Radiation Therapy, RADIATION: Intensity-Modulated Radiation Therapy, DRUG: Triapine, RADIATION: Brachytherapy
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: AstraZeneca, NRG Oncology
Intervention / Treatment: DRUG: Carboplatin, PROCEDURE: Magnetic Resonance Imaging, OTHER: Laboratory Biomarker Analysis, OTHER: Pharmacological Study, PROCEDURE: Biospecimen Collection, DRUG: Gemcitabine Hydrochloride, DRUG: Olaparib, OTHER: Quality-of-Life Assessment, DRUG: Gemcitabine, DRUG: Paclitaxel, PROCEDURE: Computed Tomography, PROCEDURE: Multigated Acquisition Scan, DRUG: Pegylated Liposomal Doxorubicin Hydrochloride, PROCEDURE: Echocardiography Test, DRUG: Cediranib Maleate
Lead Sponsor: University of Alabama at Birmingham
Collaborators: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: LDE225